These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23272093)

  • 1. Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer.
    Benamrouz S; Guyot K; Gazzola S; Mouray A; Chassat T; Delaire B; Chabé M; Gosset P; Viscogliosi E; Dei-Cas E; Creusy C; Conseil V; Certad G
    PLoS One; 2012; 7(12):e51232. PubMed ID: 23272093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
    Hikosaka K; Satoh M; Koyama Y; Nakai Y
    Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Cryptosporidium parvum-induced gastrointestinal neoplasia in severe combined immunodeficiency (SCID) mice: severity of lesions is correlated with infection intensity.
    Certad G; Creusy C; Ngouanesavanh T; Guyot K; Gantois N; Mouray A; Chassat T; Flament N; Fleurisse L; Pinon A; Delhaes L; Dei-Cas E
    Am J Trop Med Hyg; 2010 Feb; 82(2):257-65. PubMed ID: 20134002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids.
    Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A
    Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent response to challenge infection with Cryptosporidium parvum in immunosuppressed C57BL/6N mice.
    Surl CG; Kim HC
    J Vet Sci; 2006 Mar; 7(1):47-51. PubMed ID: 16434849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Ablation of a Female-Specific Apetala 2 Transcription Factor Blocks Oocyst Shedding in Cryptosporidium parvum.
    Tandel J; Walzer KA; Byerly JH; Pinkston B; Beiting DP; Striepen B
    mBio; 2023 Apr; 14(2):e0326122. PubMed ID: 36786597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morpholino-mediated in vivo silencing of Cryptosporidium parvum lactate dehydrogenase decreases oocyst shedding and infectivity.
    Zhang X; Kim CY; Worthen T; Witola WH
    Int J Parasitol; 2018 Jul; 48(8):649-656. PubMed ID: 29530646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in mouse circulating leukocyte numbers in C57BL/6 mice immunosuppressed with dexamethasone for Cryptosporidium parvum oocyst production.
    Miller TA; Schaefer FW
    Vet Parasitol; 2007 Nov; 149(3-4):147-57. PubMed ID: 17904293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptosporidium parvum, a potential cause of colic adenocarcinoma.
    Certad G; Ngouanesavanh T; Guyot K; Gantois N; Chassat T; Mouray A; Fleurisse L; Pinon A; Cailliez JC; Dei-Cas E; Creusy C
    Infect Agent Cancer; 2007 Nov; 2():22. PubMed ID: 18031572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinase-like Protease 1 Contributes to Macrogamont Formation in Cryptosporidium parvum.
    Xu R; Feng Y; Xiao L; Sibley LD
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viability and infectivity of Cryptosporidium parvum oocysts detected in river water in Hokkaido, Japan.
    Tsushima Y; Karanis P; Kamada T; Xuan X; Makala LH; Tohya Y; Akashi H; Nagasawa H
    J Vet Med Sci; 2003 May; 65(5):585-9. PubMed ID: 12808210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptosporidium parvum infection in experimentally infected mice: infection dynamics and effect of immunosuppression.
    Tarazona R; Blewett DA; Carmona MD
    Folia Parasitol (Praha); 1998; 45(2):101-7. PubMed ID: 9684319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts.
    Petry F; Robinson HA; McDonald V
    J Clin Microbiol; 1995 Jul; 33(7):1922-4. PubMed ID: 7665672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers.
    Chappell CL; Okhuysen PC; Sterling CR; DuPont HL
    J Infect Dis; 1996 Jan; 173(1):232-6. PubMed ID: 8537664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant cryptosporidiosis associated with digestive adenocarcinoma in SCID mice infected with Cryptosporidium parvum TUM1 strain.
    Certad G; Creusy C; Guyot K; Mouray A; Chassat T; Delaire B; Pinon A; Sitja-Bobadilla A; Alvarez-Pellitero P; Praet M; Cuvelier C; Dei-Cas E
    Int J Parasitol; 2010 Nov; 40(13):1469-75. PubMed ID: 20708621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
    Hønsvall BK; Robertson LJ
    Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
    Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
    Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence of geographically different Cryptosporidium parvum isolates in experimental animal model.
    Sayed FG; Hamza AI; Galal LA; Sayed DM; Gaber M
    Ann Parasitol; 2016 Oct; 62(3):221-32. PubMed ID: 27770762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts.
    Jenkins MB; Anguish LJ; Bowman DD; Walker MJ; Ghiorse WC
    Appl Environ Microbiol; 1997 Oct; 63(10):3844-50. PubMed ID: 9327547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.